ACRN is leading a team of senior-level pharmaceutical industry partners and the global health partners on a tour of Rwanda, Zimbabwe, and South Africa, from March 24 to March 28.
The tour is part of our aim to develop a robust life sciences industry on the continent by strengthening partnerships with governments, public health institutions and other stakeholders for effective clinical trials and vaccine capabilities in Africa.
During the visit, ACRN will highlight the capabilities and challenges in the region, facilitating discussions with government officials, public health representatives, regulators, and other key players in the clinical trials and research sector.
The ACRN delegation at the Rwanda Development Board
The team, visiting the Rwanda Military Hospital
The delegation led by ACRN met with Juliana Muganza, Deputy CEO of Rwanda Development Board, and Michelle Umurungi, Chief Investment Officer of RDB. The group discussed the life sciences landscape in Rwanda and opportunities to engage in the ecosystem.
Emmanuel Tekiryq, takes the ACRN delegation on tour of the CFHR (Centre for Family Health Rwanda) Lab.